Lupron Depot® (leuprolide
acetate for depot suspension)
General Information: Lupron Depot®
is typically utilized in the pallative treatment of advanced
prostate cancer and in the management of endometriosis. For indications, dosing and other information, please refer to the manufacturer package insert.
|
| |
| Manufacturer |
Product |
Size |
NDC |
PI |
MSDS |
|
Abbott |
Lupron Depot® |
3.75 mg |
00074-3641-03 |
PI |
MSDS |
| |
|
7.5 mg |
00074-3642-03 |
PI |
MSDS |
| |
|
11.25 mg |
00074-3663-03 |
PI |
MSDS |
| |
|
22.5 mg (3 month) |
00074-3346-03 |
PI |
MSDS |
| |
|
30 mg (4 month) |
00074-3683-03 |
PI |
MSDS |
|
| |
| Clinical
Data: For any questions
or for further information
related to Lupron Depot
or Lupron Depot-PED, clinical
pharmacology, additional
indications and usages,
contraindications, warnings,
precautions, adverse reactions,
dosage, administration and/or
storage of this product, please
contact
BDI Pharma or call 1-800-948-9834. |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |